Centene posted a net loss of $6.6 billion in the third quarter after recording a massive charge to reflect the company’s waning value amid challenging market conditions, including Republican cuts to ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer offered his take on Centene and the broader health insurance space as its stock plummeted when management unexpectedly withdrew full-year guidance.

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Health insurer Centene reported a $6.6 billion third-quarter loss as the ...

Centene issued a higher earnings outlook for 2026 than analysts expected, while beating Wall Street forecasts for earnings and revenue in the fourth quarter — a rare outperformance during a difficult ...

Centene‘s stock has experienced a significant decline—more than 42% in the past six months—primarily due to the withdrawal of its 2025 financial guidance following some troubling developments in its ...

Centene's stock has plummeted due to surging medical costs and a surprise Q2 loss. Despite new, lower 2025 guidance causing a slight pop, the company faces "hurricane level headwinds" like potential ...

Health coverage company Centene (NYSE:CNC) in Q4 CY2025, with sales up 21.9% year on year to $49.73 billion. On the other hand, the company’s full-year revenue guidance of $188.5 billion at the ...